Rubicon Research Limited is an India-based pharmaceutical company specializing in the development, manufacturing, and commercialization of generic and specialty formulations. The company focuses on a broad range of dosage forms, including oral solids, oral liquids, nasal sprays, injectables, ophthalmic, and drug-device combinations. Rubicon operates two US FDA-approved manufacturing facilities in Ambernath and Satara, Maharashtra, and maintains R&D centers in Thane, India, and Concord, Canada. The company was incorporated in 1999 and is located in Thane, India.
Legal Address
MedOne House, B-75, Road No. 33, Wagle Estate,, ,
Thane; Maharashtra;
Postal Code: 400604
Contact Details: Purchase the Rubicon Research Ltd. report to view the information.
Website: http://www.rubicon.co.in
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service